| Dr Diedra Deanne Wuenschel, DO | |
|
1507 W Main St, Gatesville, TX 76528-1024 | |
| (254) 865-2166 | |
| (254) 248-0626 |
| Full Name | Dr Diedra Deanne Wuenschel |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 16 Years |
| Location | 1507 W Main St, Gatesville, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902105471 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | N4854 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Solaris Hospice Inc | Decatur, TX | Hospice |
| Bluebonnet Health Services | Waco, TX | Hospice |
| Coryell Memorial Healthcare System | Gatesville, TX | Hospital |
| Hillview Nursing & Rehabilitation | Goldthwaite, TX | Nursing home |
| The Meadows | Gatesville, TX | Nursing home |
| Goldthwaite Health & Rehab Center | Goldthwaite, TX | Nursing home |
| Hillside Medical Lodge | Gatesville, TX | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Coryell County Memorial Hospital Authority | 7719886282 | 25 |
News Archive
The Food and Drug Administration can promote progress toward personalized medicine by approaching the oversight of laboratory developed tests (LDTs) in a focused, flexible, and balanced way according to the American Clinical Laboratory Association (ACLA). ACLA, which represents the nation's leading clinical laboratories, says that the factors supporting this approach include the growing role that such tests play in clinical decision making, especially in the area of new advanced diagnostics that derive from the mapping of the human genome and help fulfill the promise of personalized medicine.
Results of a subanalysis from the FAIR-HF study demonstrate that correcting iron deficiency with Ferinject (ferric carboxymaltose) can improve renal function in chronic heart failure patients. Ferinject is an intravenous iron product used to treat iron deficiency and iron deficiency anaemia.
The Canadian Medical Association (CMA) welcomed today the unanimous ruling by the Supreme Court of Canada allowing Vancouver's supervised drug injection facility, Insite, to continue to operate.
Immunomodulatory drugs, including the Contergan derivatives lenalidomide and pomalidomide, have significantly improved the therapy of hematologic malignancies such as multiple myeloma.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the QUANTUM-R Phase 3 clinical trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation.
› Verified 9 days ago
| Entity Name | Coryell County Memorial Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992832521 PECOS PAC ID: 7719886282 Enrollment ID: O20040202000105 |
News Archive
The Food and Drug Administration can promote progress toward personalized medicine by approaching the oversight of laboratory developed tests (LDTs) in a focused, flexible, and balanced way according to the American Clinical Laboratory Association (ACLA). ACLA, which represents the nation's leading clinical laboratories, says that the factors supporting this approach include the growing role that such tests play in clinical decision making, especially in the area of new advanced diagnostics that derive from the mapping of the human genome and help fulfill the promise of personalized medicine.
Results of a subanalysis from the FAIR-HF study demonstrate that correcting iron deficiency with Ferinject (ferric carboxymaltose) can improve renal function in chronic heart failure patients. Ferinject is an intravenous iron product used to treat iron deficiency and iron deficiency anaemia.
The Canadian Medical Association (CMA) welcomed today the unanimous ruling by the Supreme Court of Canada allowing Vancouver's supervised drug injection facility, Insite, to continue to operate.
Immunomodulatory drugs, including the Contergan derivatives lenalidomide and pomalidomide, have significantly improved the therapy of hematologic malignancies such as multiple myeloma.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the QUANTUM-R Phase 3 clinical trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Diedra Deanne Wuenschel, DO 1507 W Main St, Gatesville, TX 76528-1024 Ph: (254) 865-2166 | Dr Diedra Deanne Wuenschel, DO 1507 W Main St, Gatesville, TX 76528-1024 Ph: (254) 865-2166 |
News Archive
The Food and Drug Administration can promote progress toward personalized medicine by approaching the oversight of laboratory developed tests (LDTs) in a focused, flexible, and balanced way according to the American Clinical Laboratory Association (ACLA). ACLA, which represents the nation's leading clinical laboratories, says that the factors supporting this approach include the growing role that such tests play in clinical decision making, especially in the area of new advanced diagnostics that derive from the mapping of the human genome and help fulfill the promise of personalized medicine.
Results of a subanalysis from the FAIR-HF study demonstrate that correcting iron deficiency with Ferinject (ferric carboxymaltose) can improve renal function in chronic heart failure patients. Ferinject is an intravenous iron product used to treat iron deficiency and iron deficiency anaemia.
The Canadian Medical Association (CMA) welcomed today the unanimous ruling by the Supreme Court of Canada allowing Vancouver's supervised drug injection facility, Insite, to continue to operate.
Immunomodulatory drugs, including the Contergan derivatives lenalidomide and pomalidomide, have significantly improved the therapy of hematologic malignancies such as multiple myeloma.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the QUANTUM-R Phase 3 clinical trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation.
› Verified 9 days ago
Dr. Charles Rismyhr, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 319 Highway 36 Byp S, Ste 401, Gatesville, TX 76528 Phone: 254-248-6500 | |
Dr. Timothy Michael Dannemiller, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1507 W Main St, Gatesville, TX 76528 Phone: 254-865-2166 Fax: 254-248-0626 | |
Christopher Jason Long, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1507 W Main St, Gatesville, TX 76528 Phone: 254-865-8251 Fax: 254-248-6306 | |
Mark H Gibby, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1507 W Main St, Gatesville, TX 76528 Phone: 254-865-2166 | |
Zoe Michelle Walker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1507 W Main St, Gatesville, TX 76528 Phone: 254-865-2166 Fax: 254-248-6306 | |
Jantzen Matli, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1507 W Main St, Gatesville, TX 76528 Phone: 254-865-2166 Fax: 254-248-0626 | |
Joanne E Pritchard, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 319 Highway 36 Byp S, Gatesville, TX 76528 Phone: 254-248-6500 |